This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: acute patients. In patients with clinical symptoms, patients should be started on a phlebotomy regimen. This would involve weekly phlebotomy sessions to reduce serum ferritin level to ≤120 picomol/L. This should be continued over time to maintain serum iron below this level. If phlebotomy is contraindicated (e.g. severe anaemia, heart disease), patients should be treated with oral iron-chelating agents such as deferasirox (0-30 mg/kg/day). Prognosis Treatment returns life expectancy to normal if patient non cirrhotic and no diabetic Joint problems may / may not improve Hypogonadism irreversible > 10% of cirrhotic patients will develop Increased risk of hepatocellular carcinoma Prevention Patients should be advised by their family physician and spet to avoid additional supplementation of iron and vitamin C....
View Full Document
This note was uploaded on 12/04/2011 for the course ANTHRO 2000 taught by Professor Monicaoyola during the Fall '10 term at Broward College.
- Fall '10